NCT00431249: Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease |
|
|
| Completed | 4 | 40 | RoW | Cilostazol | Tungs' Taichung Metroharbour Hospital | Hemodialysis Patients, Peripheral Vascular Disease | 04/08 | 04/08 | | |
NCT01188824: The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) |
|
|
| Completed | 4 | 801 | RoW | Cilostazol, Pletaal®, placebo | China Medical University Hospital, National Taiwan University Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tri-Service General Hospital, Far Eastern Memorial Hospital, Changhua Christian Hospital, Chi Mei Medical Hospital, National Cheng-Kung University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, E-DA Hospital, Mackay Memorial Hospital, Cathay General Hospital, En Chu Kong Hospital, Kuang Tien General Hospital, Chung Shan Medical University, Taipei Veterans General Hospital, Taiwan | Ischemic Stroke | 07/13 | 07/13 | | |
NCT01952756: Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD) |
|
|
| Completed | 4 | 44 | RoW | Cilostazol, Pletaal (brand name), Dummy Placebo, Placebo, Control | National Cheng-Kung University Hospital, Department of Health, Executive Yuan, R.O.C. (Taiwan) | Peripheral Arterial Diseases | 09/13 | 09/13 | | |
